Global Blood Screening Market

Global Blood Screening Market Size, Share, Growth Analysis, By Product Type(Reagents & Kits, Instruments), By End User(Hospitals & Clinics, Blood Banks) - Industry Forecast 2024-2031

Report ID: SQMIG35J2044 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 64 | Figures: 77

Global Blood Screening Market News

  • In April 2022, one of the top precision oncology companies, Guardant Health, Inc., has introduced the next-generation Guardant SHIELD multi-cancer assay, which is currently under research. In a single blood test, this assay is intended to examine about 20,000 epigenomic indicators that are useful for the detection of a variety of solid cancers.
  • In March 2022, for speedy and precise microbiological detection of positive blood cultures, Accelerate Diagnostics introduced the Accelerate Arc system.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Blood Screening Market size was valued at USD 2.73 Billion in 2022 and is poised to grow from USD 2.96 Billion in 2023 to USD 5.69 Billion by 2031, at a CAGR of 8.50% during the forecast period (2024-2031).

The competitive landscape of the blood screening market includes information by competitor. The company's financials, revenue generated, market potential, investment in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width Details like depth, breadth, and application dominance are also presented. The data presented here only refers to blood screening as a market emphasis for the companies. 'Abbott Laboratories (USA)', 'Becton, Dickinson and Company (USA)', 'Bio-Rad Laboratories, Inc. (USA)', 'bioMérieux SA (France)', 'F. Hoffmann-La Roche Ltd. (Switzerland)', 'Grifols, S.A. (Spain)', 'Hologic, Inc. (USA)', 'Immucor, Inc. (USA)', 'Meridian Bioscience, Inc. (USA)', 'Ortho Clinical Diagnostics (USA)', 'Quotient Limited (UK)', 'Siemens Healthineers AG (Germany)', 'Sysmex Corporation (Japan)', 'Thermo Fisher Scientific Inc. (USA)', 'Danaher Corporation (USA)', 'Grifols Diagnostic Solutions Inc. (USA)', 'Haemonetics Corporation (USA)', 'Luminex Corporation (USA)', 'Natera, Inc. (USA)', 'Novartis International AG (Switzerland)', 'PerkinElmer, Inc. (USA)', 'Promega Corporation (USA)'

There is a growing awareness among healthcare professionals and patients about the risks associated with blood transfusions, such as the transmission of infectious diseases. This is leading to an increased demand for blood screening products that can ensure the safety of blood and blood products.

The demand for plasma-derived products, such as immunoglobulins and clotting factors, is growing, and this is driving the demand for blood screening products that can ensure the safety of these products. This trend is expected to continue as the use of plasma-derived products expands into new therapeutic areas.

A growing prevalence of renal, heart, and bacterial diseases in nations like India and China is predicted to cause the Asia Pacific market to represent the greatest revenue share in the global market during the projection period. In India, chronic kidney disease affects more than 7.8 million people. In addition to these factors, the market revenue growth is being fueled by increased government and corporate efforts to increase public knowledge and confidence. A rise in cardiovascular diseases and changes in lifestyle are two other elements influencing the market's revenue growth. The largest population of diabetic patients worldwide, at over 141 million, is found in China.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Blood Screening Market

Report ID: UCMIG35J2107 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Veterinary Biomarkers Market
Buy Now GET FREE SAMPLE
Global Blood Screening Market

Report ID: SQMIG35J2105 | Region: Global | Published Date: April, 2024 | Pages: 219 | Tables: 36 | Figures: 74

Global Legal Cannabis Market
Buy Now GET FREE SAMPLE
Global Blood Screening Market

Report ID: UCMIG35J2089 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Cardiac Catheters & Guidewires Market
Buy Now GET FREE SAMPLE
Global Blood Screening Market

Report ID: UCMIG35J2064 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Telepsychiatry Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Blood Screening Market

Product ID: SQMIG35J2044

$5,300
BUY NOW GET FREE SAMPLE